Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze APGE stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate APGE investment potential.

What is APGE stock price today?

Get real-time APGE stock price, historical data, and price charts on Financhill. Track APGE performance with our advanced analysis tools.

Is APGE a good investment?

Evaluate APGE investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy APGE stock?

To buy APGE stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of APGE?

View detailed market capitalization data and company valuation metrics for APGE on our comprehensive analysis page.

What is the P/E ratio of APGE?

Use our fundamental analysis tools to view APGE P/E ratio and compare valuation metrics with industry peers.

What are APGE earnings?

View APGE earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Apogee Therapeutics, Inc. Stock Predictions

Still Time to Get In: RAD Intel at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

APGE
Apogee Therapeutics, Inc.

Last Price:

$76.85

Seasonality Move:

39.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Missed $0.81? RAD Intel Now Open at $0.85/Share

Apogee Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Apogee Therapeutics, Inc. has on average historically risen by 96.9% based on the past 2 years of stock performance.
Apogee Therapeutics, Inc. has risen higher in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Is Apogee Therapeutics, Inc. Stock Undervalued?

The current Apogee Therapeutics, Inc. [APGE] share price is $76.75. The Score for APGE is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
APGE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Apogee Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Apogee Therapeutics, Inc. has on average historically risen by 96.9% based on the past 2 years of stock performance.

Apogee Therapeutics, Inc. Stock Rating

Buy

Apogee Therapeutics, Inc. (APGE) is a Buy

Is Apogee Therapeutics, Inc. overpriced?

Apogee Therapeutics, Inc. has risen higher in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Apogee Therapeutics, Inc. Stock Price History

Is APGE stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

apogeetherapeutics.com

52-Week Data

52-Week High:

77.09

52-Week Low:

26.20

Prediction Charts

Market Cap:

5.2B

Price in USD:

76.75

Volume:

733.7K

Beta:

1.45

Technical Analysis

SMA50:

56.94

SMA100:

47.33

SMA200:

42.61

52-Wk Change:

62.74%

Stock Predictions

Is Apogee Therapeutics, Inc. stock public?

Yes, Apogee Therapeutics, Inc. is a publicly traded company.
What is the Apogee Therapeutics, Inc. stock quote today?

The Apogee Therapeutics, Inc. stock price is 76.75 USD today.
How to buy Apogee Therapeutics, Inc. stock online?

You can buy Apogee Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-17	65.24	64.83	67.10	63.75
Nov-18	63.89	63.91	64.84	61.81
Nov-19	63.19	63.83	65.88	63.13
Nov-20	64.93	63.37	67.66	63.00
Nov-21	63.23	66.26	66.88	62.89
Nov-24	67.41	67.85	69.84	67.20
Nov-25	67.66	70.92	71.13	67.66
Nov-26	72.71	70.39	73.90	69.46
Nov-28	70.92	71.97	72.32	70.56
Dec-1	71.97	68.96	71.99	68.72
Dec-2	69.28	69.13	70.07	67.68
Dec-3	69.56	74.55	74.99	69.17
Dec-4	73.66	75.50	77.00	73.51
Dec-5	74.88	76.75	77.09	74.36

Apogee Therapeutics, Inc. Earnings

Apogee Therapeutics, Inc. Earnings Report: Per Share Apogee Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Apogee Therapeutics, Inc. Forecast Revenue Growth

Apogee Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Apogee Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.12 per share, and a decrease next year of $0.59 per share.

* Apogee Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.